is semaglutide safe for heart patients FDA Approves Wegovy to Reduce Disease and Stroke Risk in People With Obesity Semaglutides (Ozempic & Wegovy) &

Risks include: Contamination from improper handling or manufacturing Incorrect dosing leading to overdose or lack of effect Unknown ingredients or mislabeled products Dangerous side effects without medical monitoring Mental Health Risks of Unregulated GLP-1 Use At Montare, we treat many patients whose mental health conditions are worsened by unregulated medication use

To confirm whether any product is a licensed medicine, consumers can look for a UK Product Licence (PL) number on the packaging

Funded by the South African Medical Research Council

"Our differentiation lies in adapting therapies to realities of the Indian market through greater accessibility, flexible delivery formats, and a strong focus on adherence," explains Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals

As more and more treatment options with GLP-1 agonists become available, the demand will continue to increase (Table 1)

Unravelling the gastroprotective potential of Kefir: exploring antioxidant effects in preventing gastric ulcers